TD Asset Management »

Amylyx Pharmaceuticals shares owned by TD Asset Management

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by TD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $557k 41k 13.59
2024-03-31 $373k 131k 2.84
2023-12-31 $1.7M 115k 14.72

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
Enbridge (ENB)
Cibc Cad (CM)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Brookfield Corp Cl A Ltd Vt Sh (BN)
JPMorgan Chase & Co. (JPM)
Agnico (AEM)

View all positions for TD Asset Management

Top funds holding Amylyx Pharmaceuticals

FMR
Perceptive Advisors
BlackRock
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Saturn V Capital Management
Commodore Capital
First Light Asset Management
Point72 Asset Management
Henderson Group
Driehaus Capital Management
Almitas Capital
Goldman Sachs Group
Paradigm Biocapital Advisors

View all funds holding Amylyx Pharmaceuticals